Chris Andrews

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

Kunle Odunsi, Feng Qian, Junko Matsuzaki et al. · Proceedings of the National Academy of Sciences · 2007 · 266 citations · Full text

Histocompatibility, Cancer Vaccine Design, Immunology +21

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Carolyn Crandall, Kathleen M. Hovey, Chris Andrews et al. · Menopause The Journal of The North American Menopause Society · 2017 · 250 citations · Full text

Seromic profiling of ovarian and pancreatic cancer

Sacha Gnjatic, Erika Ritter, Markus W. Büchler et al. · Proceedings of the National Academy of Sciences · 2010 · 171 citations · Full text

Immunology, Pathology, Elisa Validation +17

Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States

Sophia Y. Wang, Chris Andrews, William H. Herman et al. · Ophthalmology · 2016 · 151 citations · Full text

Type 1, Diabetic Retinopathy, Ocular Disease +10

Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

Feng Qian, Jeannine Villella, Paul K. Wallace et al. · Cancer Research · 2009 · 148 citations · Full text